Importantly, we also uncovered that loss of Smad7 in CD4+ T cells was associated with dysregulation of Th17/Treg by enhancing Th17 over Treg response, providing the first clinical evidence for the potential role of Smad7 in CD4+ T cell-mediated RA. The gene discussed is CD4; the disease is rheumatoid arthritis.